Nothing Special   »   [go: up one dir, main page]

再鼎医药
屏蔽该公司
取消屏蔽

制药· 2000-5000人· 美股上市

Zai Lab is a ********biotech company based in China focused on discovering and developing innovative medicines for unmet medical needs globally. The company is building a strong portfolio of therapeutic programs aimed at transforming patients’ lives. Zai Lab has a world class leadership team with deep experience at global pharmaceutical and biotech organizations. The team has a strong track record of success – successfully taken five novel drug candidates into clinical trials in China, pioneered new regulatory channels, secured regulatory approvals in record times, conducted multiple IND trials in the US, and brought the first China discovered drug into Global Phase III trials. Zai Lab is committed to build a globally ********drug research and development powerhouse with a culture of excellence and teamwork and a strong focus on fostering innovation and creativity. For more information, please visit **********************
...
查看全部 收起
融资情况
092020
IPO 未披露
投资机构: 未公开
052019
战略投资 2.00亿美元
投资机构: 未公开
062017
C轮 3000.00万美元
投资机构: Rock Springs Capital
012016
B轮 1.00亿美元
投资机构: 启明创投 / 尚珹投资 / 泰福资本 / 红杉中国
082014
A轮 3000.00万美元
投资机构: 启明创投 / 泰福资本 / 红杉中国
  
融资时间线